The Optimal Scope of FDA Regulation of Genetic Tests: Meeting Challenges and Keeping Promises.
Harvard Journal of Law & Technology 2007, Spring, 20, 2
-
- $5.99
-
- $5.99
Publisher Description
I. INTRODUCTION With the completion of the Human Genome Project and the advent of increasingly sophisticated genetic technologies, the promise that genetic advances will revolutionize medicine appears closer than ever. Soon, tests will function as medical crystal balls, forecasting risks of disease years into the future based on genetic variations. Medical care might soon benefit from tests that accurately predict the risk of common diseases with complex etiologies, such as cancers, Parkinson's disease, or Alzheimer's disease. (1)
Promoting Safe and Effective Genetic Tests in the United States: Work of the Task Force on Genetic Testing (Clinical Chemistry Forum)
1999
An Evidence Framework for Genetic Testing
2017
Principles and Practice of Clinical Research
2011
Ensuring Accurate Molecular Genetic Testing (Editorial)
1998
Practical Handbook of Clinical Investigation
2016
Clinical and Translational Science
2016
Embryonic Stem Cell Research and the Theory of Medical Self-Defense.
2008
Tragedy of the Data Commons (Privacy Risks of Research Data)
2011
A Knot in the Eternal Golden Braid: Searching for Coherence in the Relationship Between Enablement, Anticipation, And Obviousness.
2010
The Wealth of Networks: How Social Production Transforms Markets and Freedom (Book Review)
2006
Privacy and the Modern Grid.
2011
Stream Capture: Returning Control of Digital Music to the Users.
2011